J Gen Virol Faster Access
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 3 (1968), 129-131; DOI 10.1099/0022-1317-3-1-129
© 1968 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shigeta, S.
Right arrow Articles by Ishida, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shigeta, S.
Right arrow Articles by Ishida, N.
Agricola
Right arrow Articles by Shigeta, S.
Right arrow Articles by Ishida, N.

The Cell to Cell Infection of Respiratory Syncytial Virus in HEp-2 Monolayer Cultures

S. Shigeta*, Y. Hinuma, T. Suto{dagger} and N. Ishida

Department of Bacteriology Tohoku University School of Medicine, Sendai, Japan

In general, the properties of respiratory syncytial virus are similar to those of myxoviruses (Chanock, Roizman & Myers, 1957; Hamparian, Hilleman & Ketler, 1963). One of the interesting properties of respiratory syncytial virus infection in vitro is syncytium formation (Jordan, 1962; Kisch, Johnson & Chanock, 1962). It has also been reported that the development of syncytia is influenced by the composition of the medium, the type of host cells (Jordan, 1962) and the incubation temperature (Suto et al. 1965), but it is not inhibited by the presence of virus antibody in the medium (Taylor-Robinson & Doggett, 1963). In the present studies, we report evidence of cell to cell infection with respiratory syncytial virus by successful transfer of virus antigen from infected cells to uninfected cells in the presence of antiviral serum.

The LONG strain of respiratory syncytial virus supplied by Dr R. M. Chanock (National Institutes of Health, Bethesda, Md, U.S.A.) was used throughout.

* Present address: Roswell Park Memorial Institute, Buffalo, New York, U.S.A.

{dagger} Present address: Department of Microbiology, Akita Prefectural Central Hospital, Akita, Japan.

Received 4 September 1967; accepted 10 February 1968.


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
P. J. M. Openshaw and J. S. Tregoning
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Clin. Microbiol. Rev., July 1, 2005; 18(3): 541 - 555.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. G. P. Oomens and G. W. Wertz
trans-Complementation Allows Recovery of Human Respiratory Syncytial Viruses That Are Infectious but Deficient in Cell-to-Cell Transmission
J. Virol., September 1, 2004; 78(17): 9064 - 9072.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
J. B. Domachowske and H. F. Rosenberg
Respiratory Syncytial Virus Infection: Immune Response, Immunopathogenesis, and Treatment
Clin. Microbiol. Rev., April 1, 1999; 12(2): 298 - 309.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1968 by the Society for General Microbiology.